Filing Flows › Yarrow Bioscience (YARW) › R&D spending
Yarrow Bioscience (YARW) R&D spending by quarter
Yarrow Bioscience's R&D spending was $788K in Q2 2026 (second quarter 2026), -4% from Q1 2026. Over the last 5 quarters it ranged from $788K (Q2 2026) to $9.7M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $788K | -4% | -84% |
| Q1 2026 | $817K | -83% | -87% |
| Q2 2025 | $4.9M | -20% | — |
| Q1 2025 | $6.1M | -37% | — |
| Q4 2024 | $9.7M | — | — |
Q2 2026 at a glance
Yarrow Bioscience, Q2 2026: revenue $97K (+41% year over year), net loss $3.0M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Yarrow Bioscience's R&D spending?
Yarrow Bioscience's R&D spending was $788K in Q2 2026 (second quarter 2026), -4% from Q1 2026.
How has Yarrow Bioscience's R&D spending changed?
Over the last 5 quarters it ranged from $788K (Q2 2026) to $9.7M (Q4 2024).